Free Trial
ASX:API

Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

Australian Pharmaceutical Industries logo

About Australian Pharmaceutical Industries Stock (ASX:API)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
453,647 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.29%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive API Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

API Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel
Elon Musk's xAI launched its own API
See More Headlines

API Stock Analysis - Frequently Asked Questions

Australian Pharmaceutical Industries Limited (ASX:API) released its quarterly earnings data on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.05 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Downer EDI (DOW).

Company Calendar

Last Earnings
4/17/2019
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Medical Equipment Wholesale
Sub-Industry
Computer Software
Current Symbol
ASX:API
CIK
N/A
Fax
N/A
Employees
1,310
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.28
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
71.32
Current Ratio
1.20
Quick Ratio
0.77

Sales & Book Value

Annual Sales
A$4.00 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
8.26
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
492,656,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ASX:API) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners